Literature DB >> 28258421

Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction.

Daniel H Katz1, Rahul C Deo2, Frank G Aguilar3, Senthil Selvaraj3, Eva E Martinez3, Lauren Beussink-Nelson3, Kwang-Youn A Kim4, Jie Peng4, Marguerite R Irvin5, Hemant Tiwari5, D C Rao6, Donna K Arnett7, Sanjiv J Shah8.   

Abstract

We sought to evaluate whether unbiased machine learning of dense phenotypic data ("phenomapping") could identify distinct hypertension subgroups that are associated with the myocardial substrate (i.e., abnormal cardiac mechanics) for heart failure with preserved ejection fraction (HFpEF). In the HyperGEN study, a population- and family-based study of hypertension, we studied 1273 hypertensive patients utilizing clinical, laboratory, and conventional echocardiographic phenotyping of the study participants. We used machine learning analysis of 47 continuous phenotypic variables to identify mutually exclusive groups constituting a novel classification of hypertension. The phenomapping analysis classified study participants into 2 distinct groups that differed markedly in clinical characteristics, cardiac structure/function, and indices of cardiac mechanics (e.g., phenogroup #2 had a decreased absolute longitudinal strain [12.8 ± 4.1 vs. 14.6 ± 3.5%] even after adjustment for traditional comorbidities [p < 0.001]). The 2 hypertension phenogroups may represent distinct subtypes that may benefit from targeted therapies for the prevention of HFpEF.

Entities:  

Keywords:  Cardiac mechanics; Heart failure with preserved ejection fraction; Hypertension; Machine learning; Speckle-tracking echocardiography

Mesh:

Year:  2017        PMID: 28258421     DOI: 10.1007/s12265-017-9739-z

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  38 in total

Review 1.  Under pressure: the search for the essential mechanisms of hypertension.

Authors:  Thomas M Coffman
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Assessment of left ventricular ejection fraction after myocardial infarction using contrast echocardiography.

Authors:  Tjebbe W Galema; Marcel L Geleijnse; Sing-Chien Yap; Ron T van Domburg; Elena Biagini; Wim B Vletter; Folkert J Ten Cate
Journal:  Eur J Echocardiogr       Date:  2008-03

Review 3.  Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies.

Authors:  C Cuspidi; C Sala; F Negri; G Mancia; A Morganti
Journal:  J Hum Hypertens       Date:  2011-11-24       Impact factor: 3.012

Review 4.  Tensor Factorization for Precision Medicine in Heart Failure with Preserved Ejection Fraction.

Authors:  Yuan Luo; Faraz S Ahmad; Sanjiv J Shah
Journal:  J Cardiovasc Transl Res       Date:  2017-01-23       Impact factor: 4.132

Review 5.  Current perspectives on systemic hypertension in heart failure with preserved ejection fraction.

Authors:  A Afşin Oktay; Sanjiv J Shah
Journal:  Curr Cardiol Rep       Date:  2014-12       Impact factor: 2.931

6.  Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.

Authors:  Emmanuel A Andreadis; George I Tsourous; Chara K Tzavara; Dimitrios X Georgiopoulos; Panagiota M Katsanou; George E Marakomichelakis; Emmanuel J Diamantopoulos
Journal:  Am J Hypertens       Date:  2007-05       Impact factor: 2.689

7.  Projections of hypertension-related renal disease in middle-aged residents of the United States.

Authors:  T V Perneger; M J Klag; H I Feldman; P K Whelton
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

8.  Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.

Authors:  Timo Suonsyrjä; Tuula Hannila-Handelberg; Kristian J Paavonen; Helena E Miettinen; Kati Donner; Timo Strandberg; Ilkka Tikkanen; Reijo Tilvis; Pertti J Pentikäinen; Kimmo Kontula; Timo P Hiltunen
Journal:  J Hypertens       Date:  2008-06       Impact factor: 4.844

9.  Archeological Echocardiography: Digitization and Speckle Tracking Analysis of Archival Echocardiograms in the HyperGEN Study.

Authors:  Frank G Aguilar; Senthil Selvaraj; Eva E Martinez; Daniel H Katz; Lauren Beussink; Kwang-Youn A Kim; Jie Ping; Laura Rasmussen-Torvik; Amita Goyal; Jin Sha; Marguerite R Irvin; Donna K Arnett; Sanjiv J Shah
Journal:  Echocardiography       Date:  2015-11-03       Impact factor: 1.724

10.  The natural history of borderline isolated systolic hypertension.

Authors:  A Sagie; M G Larson; D Levy
Journal:  N Engl J Med       Date:  1993-12-23       Impact factor: 91.245

View more
  19 in total

Review 1.  Artificial Intelligence in Cardiovascular Imaging: JACC State-of-the-Art Review.

Authors:  Damini Dey; Piotr J Slomka; Paul Leeson; Dorin Comaniciu; Sirish Shrestha; Partho P Sengupta; Thomas H Marwick
Journal:  J Am Coll Cardiol       Date:  2019-03-26       Impact factor: 24.094

Review 2.  Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.

Authors:  Sanjiv J Shah
Journal:  J Cardiovasc Transl Res       Date:  2017-06-05       Impact factor: 4.132

3.  Integrating hypertension phenotype and genotype with hybrid non-negative matrix factorization.

Authors:  Yuan Luo; Chengsheng Mao; Yiben Yang; Fei Wang; Faraz S Ahmad; Donna Arnett; Marguerite R Irvin; Sanjiv J Shah
Journal:  Bioinformatics       Date:  2019-04-15       Impact factor: 6.937

4.  Automated estimation of echocardiogram image quality in hospitalized patients.

Authors:  Christina Luong; Zhibin Liao; Amir Abdi; Purang Abolmaesumi; Teresa S M Tsang; Hany Girgis; Robert Rohling; Kenneth Gin; John Jue; Darwin Yeung; Elena Szefer; Darby Thompson; Michael Yin-Cheung Tsang; Pui Kee Lee; Parvathy Nair
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-19       Impact factor: 2.357

5.  Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society-American Society of Clinical Oncology summit.

Authors:  Catherine M Alfano; Deborah K Mayer; Smita Bhatia; Jane Maher; Jessica M Scott; Larissa Nekhlyudov; Janette K Merrill; Tara O Henderson
Journal:  CA Cancer J Clin       Date:  2019-03-08       Impact factor: 508.702

6.  Multi-Trait Genetic Analysis Reveals Clinically Interpretable Hypertension Subtypes.

Authors:  Felix Vaura; Hyunkyung Kim; Miriam S Udler; Veikko Salomaa; Leo Lahti; Teemu Niiranen
Journal:  Circ Genom Precis Med       Date:  2022-05-23

7.  Invasive Hemodynamic and Metabolic Evaluation of HFpEF.

Authors:  J Emanuel Finet; Erik H Van Iterson; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-03-26

8.  A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST).

Authors:  Evangelos K Oikonomou; David Van Dijk; Helen Parise; Marc A Suchard; James de Lemos; Charalambos Antoniades; Eric J Velazquez; Edward J Miller; Rohan Khera
Journal:  Eur Heart J       Date:  2021-07-08       Impact factor: 29.983

9.  Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.

Authors:  Matthew W Segar; Kershaw V Patel; Muthiah Vaduganathan; Melissa C Caughey; Byron C Jaeger; Mujeeb Basit; Duwayne Willett; Javed Butler; Partho P Sengupta; Thomas J Wang; Darren K McGuire; Ambarish Pandey
Journal:  Diabetologia       Date:  2021-03-13       Impact factor: 10.122

Review 10.  Machine Learning and the Future of Cardiovascular Care: JACC State-of-the-Art Review.

Authors:  Giorgio Quer; Ramy Arnaout; Michael Henne; Rima Arnaout
Journal:  J Am Coll Cardiol       Date:  2021-01-26       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.